From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

Beyond the Magic Bullet: Medical Progress Is Often Incremental - National Review
Life won’t completely return to normal while the novel coronavirus remains a threat to health and to life.
Accelerating the collection of real-world data about COVID-19 - Biocentury
The Reagan-Udall Foundation and Friends of Cancer Research are trying to put real-world data to use against COVID-19.
Politico Prescription Pulse
Document Drawer
Real-World Evidence On COVID-19: US FDA Approaching With 'Sense Of Urgency' - Pink Sheet
"Identifying key questions and core data elements is at the heart of a new initiative launched by the Reagan-Udall Foundation and Friends of Cancer Research.
First Look at Gilead Drug Virus Response to Open Data Floodgates - Bloomberg Law
"A new initiative called the 
COVID-19 Evidence Accelerator Leverages Real-World Evidence in FDA’s Response to Global Pandemic
The Reagan-Udall Foundation for the FDA (Foundation) in collaboration with Friends of Cancer Research (Friends) today announced the COVID-19 Evidence Accelerator, an expan
One-Stop Resource Helps Patients and Healthcare Providers Link to COVID-19 Clinical Trials and Expanded Access Programs
To help patients, caregivers, physicians, and other healthcare providers find COVID-19 treatment resources as quickly and easily as possible, the Reagan-Udall Foundation for the FDA today launched the onl
Reagan-Udall Foundation for the FDA Names Susan Winckler as CEO
The Reagan-Udall Foundation for the Food and Drug Administration has named
Food Industry Leader Molly Fogarty Named to Board of Directors
Molly Fogarty, Senior Vice President of Nestlé in the U.S., has been appointed to the Board of Directors for the Reagan-Udall Foundation for the Food and Drug Administration.
Nominations now closed